THOMAS COOPER to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications THOMAS COOPER has written about Xenograft Model Antitumor Assays.
Connection Strength
0.044
-
The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature. 2015 Sep 17; 525(7569):384-8.
Score: 0.025
-
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci U S A. 2011 Mar 01; 108(9):3665-70.
Score: 0.018